FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group Entacapone Tablets Recall

Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed…

The Harvard Drug Group · Livonia, MI

Risk level
Class II
Reported by FDA
Sep 29, 2021
Recall ID
D-0806-2021
Check your lot numberHow we source this data

Summary

The Harvard Drug Group recalled Entacapone Tablets starting Jul 29, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0806-2021 on Sep 29, 2021. Reason: Failed Dissolution Specifications. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications

Product description

Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC 0904-6822-04

Lot numbers, UPCs & expiration codes

Lot, expiry: N00187, 05/2022; N00245, 06/2022; N00273, 07/2022; N00355, 11/2022

Where it was sold

CO, FL, MO, OH

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0806-2021
Classification
Class II
Status
Terminated
Recall initiated
Jul 29, 2021
FDA report date
Sep 29, 2021
Quantity
1,632 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group

Original FDA data

Every field from FDA enforcement report D-0806-2021, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
88638
Address
17187 N Laurel Park Dr Ste 300
Code information
Lot, expiry: N00187, 05/2022; N00245, 06/2022; N00273, 07/2022; N00355, 11/2022
Postal code
48152-2600
Report date
Sep 29, 2021
Product type
Drugs
Recall number
D-0806-2021
Classification
Class II
Recalling firm
The Harvard Drug Group
Product quantity
1,632 cartons
Termination date
Feb 19, 2023
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152. NDC 0904-6822-04
Distribution pattern
CO, FL, MO, OH
Recall initiation date
Jul 29, 2021
Initial firm notification
Letter
Center classification date
Sep 17, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0806-2021, published Sep 29, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls